CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bifrost Biosystems announced today its launch with a vision to power efficient drug discovery through its novel automated Optical Pooled Screening (OPS) platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results